Found: 17
Select item for more details and to access through your institution.
Measured and accounted‐for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 277, doi. 10.1002/pds.5189
- By:
- Publication type:
- Article
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–2017.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 390, doi. 10.1002/pds.5187
- By:
- Publication type:
- Article
Confirming diagnoses of acute pancreatitis with commonly available electronic data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 313, doi. 10.1002/pds.5185
- By:
- Publication type:
- Article
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 292, doi. 10.1002/pds.5166
- By:
- Publication type:
- Article
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 379, doi. 10.1002/pds.5180
- By:
- Publication type:
- Article
Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 400, doi. 10.1002/pds.5182
- By:
- Publication type:
- Article
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 350, doi. 10.1002/pds.5174
- By:
- Publication type:
- Article
Empirical assessment of case‐based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 320, doi. 10.1002/pds.5161
- By:
- Publication type:
- Article
Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 342, doi. 10.1002/pds.5163
- By:
- Publication type:
- Article
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 334, doi. 10.1002/pds.5162
- By:
- Publication type:
- Article
New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self‐reports.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 304, doi. 10.1002/pds.5160
- By:
- Publication type:
- Article
Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 360, doi. 10.1002/pds.5081
- By:
- Publication type:
- Article
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 371, doi. 10.1002/pds.5118
- By:
- Publication type:
- Article
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 283, doi. 10.1002/pds.5119
- By:
- Publication type:
- Article
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 395, doi. 10.1002/pds.5096
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 1, doi. 10.1002/pds.5314
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 3, p. 402, doi. 10.1002/pds.5044
- Publication type:
- Article